# Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers

> **NCT00519519** · PHASE3 · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 126 (actual)

## Conditions studied

- Bleeding Peptic Ulcers Disease

## Interventions

- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT00519519
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-10
- **Final completion:** 2007-11
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519519, "Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00519519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*